Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University of Siena, Siena, Italy

Survival: 27.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Italy
City/State/Province: Siena
Hospital: University of Siena
Journal: Link
Date: 2/2011

This study involved male patients with advanced castration-resistant prostate cancer that were divided into two separate treatment groups. Group A included 37 patients with a median age of 72 years. Group B consisted of 35 patients with a median age of 70 years.

Patients in group A were treated with the chemotherapy agents docetaxel and epirubicin. Group B was given the chemotherapy agent docetaxel and the hormone prednisone.

The maximum adverse reaction level for each group was grade 4. Patients in group A reported grade 3-4 neutropenia, anemia, and nail changes. Group B reported grade 3-4 neutropenia and nausea/vomiting.

The reported median overall survival reported for groups A and B was 27.3 and 19.8 months, respectively.

Correspondence: Dr. R Petrioli; email:

E-mail to a Friend Email Physician More Information